Page last updated: 2024-08-22

2,2-bis(bromomethyl)-1,3-propanediol and Chronic Illness

2,2-bis(bromomethyl)-1,3-propanediol has been researched along with Chronic Illness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Das, AM; Illsinger, S; Keiser, M; Lentze, MJ; Lücke, T; Naim, HY1

Other Studies

1 other study(ies) available for 2,2-bis(bromomethyl)-1,3-propanediol and Chronic Illness

ArticleYear
Congenital and putatively acquired forms of sucrase-isomaltase deficiency in infancy: effects of sacrosidase therapy.
    Journal of pediatric gastroenterology and nutrition, 2009, Volume: 49, Issue:4

    Topics: beta-Fructofuranosidase; Carbohydrate Metabolism, Inborn Errors; Chronic Disease; Diarrhea; Dietary Supplements; Female; Humans; Infant; Malabsorption Syndromes; Male; Sequence Analysis, DNA; Sucrase-Isomaltase Complex

2009